Is Guerbet S.A. (0ELV.L) a Buy, Sell, or Hold?
LSE : 0ELV.L
Guerbet S.A.
$8.28 EUR
-$0.79 (-8.71%)
- Volume
- 328
- Average Volume
- 1.64K
- Market Capitalization
- $103.92M
- P/E Ratio
- -0.96
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $32.50
- Year Low
- $8.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.49
Company Overview
LSE
Karim Boussebaa
Drug Manufacturers - Specialty & Generic
Healthcare
0ELV.L
2778
FR
EUR
Liquidity Metrics
1.64
2.49
1.26
0.48
0.00
Sales & Valuation
$786.4M
0.13
0.39
3.31
2.49
Profitability
-$8.59
-$108.33M
-13.78%
-14.45%
-33.69%
-11.65%
P/E Metrics
-0.96
0.00
0.00
Analyst Price Target & Rating
2/5
0 Analysts
%
Financial Health Scores
2.43
3/9
$359.47M
$930.02M
$669.94M
$47.42M
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Valérie Brissart | Senior Vice President of Diagnostic Imaging |
| Eva Ohlsson | Senior Vice President of Human Resources & CSR |
| Francois Nicolas | Chief Digital Officer, SVP of Research, Development, Innovation & AI |
| Charlotte Bamiere | General Counsel and SVP of Legal Affairs & Compliance |
| Philippe Bourrinet | Chief Pharmacist, Deputy Chief Executive Officer, Senior Vice President of Development, Medical & Regulatory Affairs and Deputy MD |
| Christine Allard | Senior Vice President of Public Affairs & Corporate Communications |
| Jerome Estampes | Group CFO & SVP of Business Development & Licensing |
| François Convenant | SVP of Interventional Radiology and Global VP of Commercial & Interventional Imaging |
| Karim Boussebaa | Chief Executive Officer |
| Eric Kummer | Senior VP of Technical Operations |
Poll Results
No votes yet today — be the first to share your view!
About Guerbet S.A. (LSE:0ELV.L) Stock
Guerbet S.A. is a medical technology company focused on the innovation and commercialization of contrast media products, specialized delivery systems, medical devices, and related solutions. Its comprehensive portfolio includes a range of contrast agents such as Optiray and Xenetix, which are non-ionic iodinated agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; and Micropaque/Microtrast for diagnostic imaging. For MRI applications, it offers Dotarem (gadoteric acid-gadoterate meglumine) and Artirem (gadoteric acid). Beyond contrast agents, Guerbet supplies essential equipment like prefilled syringes, injectors, and various accessories and consumables tailored for MRI, CT, and Cath Lab procedures. The company also pioneers digital health ... solutions, featuring Contrast&Care for managing injections, Dose&Care for X-ray dose management, and icobrain, a cloud-based artificial intelligence tool that quantifies disease-specific brain structures from MR and CT images for acute and chronic neurological conditions, complemented by OptiProtect services. In the field of interventional radiology, its products include Lipiodol (ethyl esters of iodinated fatty acids derived from poppyseed oil); Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and the microcatheters SeQure and DraKon. Furthermore, Guerbet provides Hydra Vision, a digital imaging system utilized for urological, gastroenterological, and gynecological treatments, planning, and diagnostics, along with associated urology accessories and consumables. Founded in 1926, Guerbet S.A. is headquartered in Villepinte, France.
Frequently Asked Questions
-
What is the current Guerbet S.A. (0ELV.L) stock price?
-
Guerbet S.A.(LSE:0ELV.L) stock price is $8.28 in the last trading session. During the trading session, 0ELV.L stock reached the peak price of $32.50179 while $8.28 was the lowest point it dropped to. The percentage change in 0ELV.L stock occurred in the recent session was --8.71% while the dollar amount for the price change in 0ELV.L stock was -$0.79.
-
0ELV.L's industry and sector of operation?
-
The LSE listed 0ELV.L is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.
-
Who are the executives of 0ELV.L?
-
Valérie Brissart | Senior Vice President of Diagnostic Imaging
Eva Ohlsson | Senior Vice President of Human Resources & CSR
Francois Nicolas | Chief Digital Officer, SVP of Research, Development, Innovation & AI
Charlotte Bamiere | General Counsel and SVP of Legal Affairs & Compliance
Philippe Bourrinet | Chief Pharmacist, Deputy Chief Executive Officer, Senior Vice President of Development, Medical & Regulatory Affairs and Deputy MD -
How many employees does 0ELV.L have?
-
Number of 0ELV.L employees currently stands at 2778. 0ELV.L operates from 15, rue des Vanesses, Villepinte, IF 93420, FR.
-
Link for 0ELV.L official website?
-
Official Website of 0ELV.L is: https://www.guerbet.com
-
How do I contact 0ELV.L?
-
0ELV.L could be contacted at phone #33 1 45 91 50 00 and can also be accessed through its website. 0ELV.L operates from 15, rue des Vanesses, Villepinte, IF 93420, FR.
-
How many shares of 0ELV.L are traded daily?
-
The average number of 0ELV.L shares traded daily for last 3 months was 1.64K.
-
What is the market cap of 0ELV.L currently?
-
The market value of 0ELV.L currently stands at $103.92M with its latest stock price at $8.28